GMP IPO Watch
Read the newest IPO GMP updates, allotment insights, subscription trends, and stock market explainers from GMP IPO Watch.
Open IPO
Hyderabad-based Sai Parenteral's enters Day 2 of its ₹409 crore IPO with a price band of ₹372–₹392. While Day 1 saw a muted 0.05x subscription and a flat ₹0 GMP, the company’s recent Australian acquisition and strong anchor book (including Morgan Stanley) suggest a long-term story. We break down the financials and the "Noumed" factor.
Open IPO
The ₹440 crore IPO of Amir Chand Jagdish Kumar (Exports) is seeing robust demand, having already crossed the 1x mark on its first day. With the price band set at ₹201–₹212 and a ₹7 GMP, we look at why Non-Institutional Investors (NIIs) are rushing in and whether the "Three Star Export House" status makes this a long-term winner.
Open IPO
Industrial machinery specialist Tipco Engineering India is in the middle of its ₹61 crore SME IPO, open until March 25, 2026. With a massive 3-year revenue CAGR of 92% and a P/E ratio under 9x, the company looks undervalued compared to its peers. We break down the Day 2 subscription, the flat GMP, and why the "Debt Repayment" objective is a game-changer.
Open IPO
The ₹1,842 crore IPO of Central Mine Planning & Design Institute (CMPDI), a critical technical arm of Coal India, closes for subscription today, March 24, 2026. Priced at ₹163–₹172, this 100% Offer for Sale (OFS) is a value-play for those eyeing India’s core energy sector. We look at the 25% Day 2 subscription, the ₹1.50 GMP, and why long-term investors are watching this one.
Open IPO
The ₹21.67 crore IPO of Highness Microelectronics launched today, March 24, 2026, with a price band of ₹114–₹120. Operating in the specialized "rugged display" market for medical and defense sectors, the company is looking to fund a new assembly line in Mumbai. With a current GMP of ₹10 (8% gain), we analyze if this SME issue is a "buy" for your portfolio.
Open IPO
Hyderabad-based Sai Parenteral's Limited launched its ₹409 crore IPO today, March 24, 2026, with a price band of ₹372–₹392. With a bold move to acquire Australia’s Noumed Pharmaceuticals, the company is shifting from a domestic manufacturer to a global CDMO powerhouse. We analyze the 72x P/E valuation, the flat GMP, and the long-term potential of this injectable specialist.
Open IPO
Navi Mumbai-based Vivid Electromech launches its ₹130.54 crore SME IPO on March 25, 2026. With 30+ years of experience and a massive 74% revenue growth last year, the company is targeting the rapidly expanding data center and metro rail sectors. We dive into the ₹528–₹555 price band, the flat GMP, and the ambitious 3x capacity expansion plan.
Open IPO
The ₹440 crore IPO of Amir Chand Jagdish Kumar (Exports) launched today, March 24, 2026, with a price band of ₹201–₹212. A 100% fresh issue, the company is leveraging its iconic "Aeroplane" brand to fuel a massive working capital push. We look at the 29% revenue growth, the current ₹6 GMP, and whether this "Three Star Export House" fits your portfolio.
Open IPO
Mumbai-based Speciality Medicines Limited wraps up its ₹29.14 crore SME IPO today, March 24, 2026. With a portfolio of 900+ products and a massive 3x jump in profit last year, the company is looking to build its own R&D center. We dive into the current 1x subscription status, the flat GMP, and the long-term outlook for this specialty pharma distributor.
Open IPO
SME engineering firm Tipco Engineering hits the primary market today, March 23, 2026, with a price band of ₹84–₹89. Despite a flat early Grey Market Premium (GMP), the company’s 4x revenue growth over the last two years and its plans to become debt-free make it a notable entry in the industrial equipment space.
Open IPO
The ₹1,842 crore IPO of Coal India’s consultancy arm, CMPDI, is seeing a measured response on its second day of bidding. As of midday March 23, 2026, the issue is subscribed 0.09x, with retail and existing Coal India shareholders showing the most movement. With a Grey Market Premium (GMP) of ₹1.5, the market is pricing this as a long-term "Value PSU" play rather than a quick listing-gain firework.
Open IPO
Mumbai-based Speciality Medicines Limited is currently live with its ₹29.14 crore SME IPO. Priced at ₹117–₹124, this 100% fresh issue is a strategic play to pivot from distribution to in-house R&D. With Day 2 bidding underway and a listing scheduled for March 30, we break down the subscription trends, the ₹0 GMP, and the long-term potential.